Cart

0

Stocks

“3 “Strong Buy” Stocks Trading at Rock-Bottom Prices”

“Scorpio Tanker (STNG)… Overall, the Strong Buy analyst consensus rating here is unanimous, based on 4 recent Buy reviews. Scorpio Tanker is currently trading at $10.69, and its $28.75 average price target suggests a one-year upside of 168%… International Seaways… Continue Reading…

Stocks

“3 “Strong Buy” Dividend Stocks Yielding Over 9%”

“New Mountain Finance Corporation (NMFC)… Overall, the Wall Street consensus on NMFC is a Strong Buy, based on 4 reviews including 3 Buys and 1 Hold. The shares are selling for $9.88, and the average price target of $10.92 implies a… Continue Reading…

Business, Cryptocurrencies

“Square buys $50 million in bitcoin, says cryptocurrency ‘aligns with company’s purpose’”

“Square said Thursday it bought 4,709 bitcoins, worth approximately $50 million. This represents about 1% of Square’s total assets as of the end of the second quarter of 2020… The price of the digital currency has risen to around $10,724 from $7,100… Continue Reading…

Stocks

“Wells Fargo: These 3 “Strong Buy” Stocks Have Over 70% Upside Potential”

“Northern Oil and Gas (NOG)… Wall Street agrees with Hughes on the potential here; the analyst consensus rating of Strong Buy comes from a unanimous 5 positive reviews. Shares are priced at $5.30 and have an average price target of $14,… Continue Reading…

Stocks

“Buy These 3 Dividend Stocks on Weakness, Say Analysts”

“ConocoPhillips (COP)… Overall, the Strong Buy consensus rating on COP shares is based on 13 reviews, including 11 Buys and 2 Holds. The stock sells for $33.90 and has an average price target of $48.08, in line with Gresh’s… Baker… Continue Reading…

Business

“Bristol-Myers to buy heart drugs developer MyoKardia for about $13 billion”

“Bristol-Myers Squibb said on Monday it would buy MyoKardia for about $13 billion to bolster its portfolio of heart disease treatments, as it seeks to reduce some of its dependence on cancer drugs. The deal follows Bristol-Myers’ $74 billion acquisition of Celgene last… Continue Reading…

Stocks

“3 “Strong Buy” Healthcare Stocks With Major Catalysts Approaching”

“Kala Pharmaceuticals (KALA)… In general, other analysts echo Moussatos’ sentiment. 4 Buys and 1 Hold add up to a Strong Buy consensus rating. With an average price target of $20.80, the upside potential comes in at 173%… Revance Therapeutics (RVNC)…… Continue Reading…

Stocks

“8 Best Buffett Stocks to Buy for Dividends”

“Kraft Heinz Co. (KHC)… Kraft Heinz is not only one of Buffett’s largest holdings but also one of the highest-yielding stocks in Berkshire’s portfolio. Kraft Heinz shares have a 5.3% dividend… Store Capital Corp. (STOR)… Store Capital is a net-lease real estate investment… Continue Reading…

Stocks

“3 Big Dividend Stocks Yielding Over 7%; Compass Point Says ‘Buy’”

“Saratoga Investment Corporation (SAR)… Overall, Saratoga gets a unanimous Strong Buy rating from the analyst consensus, based on 3 recent positive reviews. The shares are selling for $17.02 and have an average price target of $22.58, slightly more bullish than Alexander’s… Continue Reading…

Stocks

“3 “Strong Buy” Healthcare Stocks Under $5 That Could Go Boom”

“Kintara Therapeutics (KTRA)… Are other analysts in agreement? They are. Only Buy ratings, 3 to be exact, have been issued in the last three months. Therefore, the word on the Street is that KTRA is a Strong Buy. Given the… Continue Reading…